Reports
Reports
Sale
The global balloon catheters market size was valued at USD 4.5 billion in 2023, with Europe holding a significant market share. The market is driven by the increasing prevalence of cardiovascular diseases. It is expected to grow at a CAGR of 6.5% during the forecast period of 2024-2032, with the values likely to attain USD 8.1 billion by 2032.
Balloon catheters are medical devices that are primarily utilized in minimally invasive procedures to treat narrowed or blocked vessels. The catheter is a thin and flexible tube made from medical-grade materials and a balloon is attached to its tip, which can be inflated and deflated. The rising preference for balloon catheters can be attributed to the growing demand for minimally invasive surgeries, which significantly contributes to the Europe balloon catheters market growth.
In Europe, the high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, drives the demand for balloon catheters. Recent data reveals that Eastern Europe has the highest cardiovascular disease death rates, with 553 deaths for every 100,000 individuals, indicating the urgent need for interventions that involve balloon catheters, such as angioplasty. Further, the growing aging population coupled with the presence of advanced healthcare infrastructure and high healthcare spending is expected to influence the Europe balloon catheters market share.
One of the major market trends is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by a global interventional cardiovascular device company Translumina to expand its intervention cardiology portfolio. Through this acquisition, the company is expected to gain access for Drug Coated Balloons (DCB) and other specialty balloons, that can offer new treatment possibilities to cardiovascular patients. Such strategic partnerships are expected to increase access to innovative balloon catheters across the region, thereby fuelling market growth.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Product Type | PTA Balloon Catheters, PTCA Balloon Catheters, Occlusion Balloon Catheters, Foley Catheters, Nephrostomy Balloon Catheters, Drug-Eluting Catheters, Normal Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Drug Eluting Balloon Catheter, Stent Graft Balloon Catheter, Others |
Catheter Type | Fixed Wire, Over-The-Wire, Rapid Exchange |
Balloon Type | Non-Compliant, Semi-Compliant, Compliant |
Material | Polyurethane, Nylon, Others |
Indication | Coronary Artery Disease, Peripheral Vascular Disease |
End User | Hospitals, Specialty Clinics, Others |
Countries | United Kingdom, Germany, France, Italy, others |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Catheter Type |
|
Breakup by Balloon Type |
|
Breakup by Material |
|
Breakup by Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Balloon Catheters Market Overview
3.1 Europe Balloon Catheters Market Historical Value (2017-2023)
3.2 Europe Balloon Catheters Market Forecast Value (2024-2032)
4 Europe Balloon Catheters Market Landscape*
4.1 Europe Balloon Catheters: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Balloon Catheters: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Catheters Type
4.2.3 Analysis by Balloon Type
5 Europe Balloon Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Balloon Catheters Market Segmentation (2017-2032)
6.1 Europe Balloon Catheters Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 PTA Balloon Catheters
6.1.3 PTCA Balloon Catheters
6.1.4 Occlusion Balloon Catheters
6.1.5 Foley Catheters
6.1.6 Nephrostomy Balloon Catheters
6.1.7 Drug -Eluting Catheters
6.1.8 Normal Balloon Catheter
6.1.9 Cutting Balloon Catheter
6.1.10 Scoring Balloon Catheter
6.1.11 Drug Eluting Balloon Catheter
6.1.12 Stent Graft Balloon Catheter
6.1.13 Others
6.2 Europe Balloon Catheters Market (2017-2032) by Catheter Type
6.2.1 Market Overview
6.2.2 Fixed Wire
6.2.3 Over -The -Wire
6.2.4 Rapid Exchange
6.3 Europe Balloon Catheters Market (2017-2032) by Balloon Type
6.3.1 Market Overview
6.3.2 Non-Compliant
6.3.3 Semi-Compliant
6.3.4 Compliant
6.4 Europe Balloon Catheters Market (2017-2032) by Material
6.4.1 Market Overview
6.4.2 Polyurethane
6.4.3 Nylon
6.4.4 Others
6.5 Europe Balloon Catheters Market (2017-2032) by Indication
6.5.1 Market Overview
6.5.2 Coronary Artery Disease
6.5.3 Peripheral Vascular Disease
6.6 Europe Balloon Catheters Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Specialty Clinics
6.6.4 Others
6.7 Europe Balloon Catheters Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 United Kingdom
6.7.3 Germany
6.7.4 France
6.7.5 Italy
6.7.6 Others
7 United Kingdom Balloon Catheters Market (2017-2032)
7.1 United Kingdom Balloon Catheters Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 PTA Balloon Catheters
7.1.3 PTCA Balloon Catheters
7.1.4 Occlusion Balloon Catheters
7.1.5 Foley Catheters
7.1.6 Nephrostomy Balloon Catheters
7.1.7 Drug -Eluting Catheters
7.1.8 Normal Balloon Catheter
7.1.9 Cutting Balloon Catheter
7.1.10 Scoring Balloon Catheter
7.1.11 Drug Eluting Balloon Catheter
7.1.12 Stent Graft Balloon Catheter
7.1.13 Others
7.2 United Kingdom Balloon Catheters Market (2017-2032) by Catheter Type
7.2.1 Market Overview
7.2.2 Fixed Wire
7.2.3 Over -The -Wire
7.2.4 Rapid Exchange
7.3 United Kingdom Balloon Catheters Market (2017-2032) by Balloon Type
7.3.1 Market Overview
7.3.2 Non-Compliant
7.3.3 Semi-Compliant
7.3.4 Compliant
7.4 United Kingdom Balloon Catheters Market (2017-2032) by Material
7.4.1 Market Overview
7.4.2 Polyurethane
7.4.3 Nylon
7.4.4 Others
7.5 United Kingdom Balloon Catheters Market (2017-2032) by Indication
7.5.1 Market Overview
7.5.2 Coronary Artery Disease
7.5.3 Peripheral Vascular Disease
7.6 United Kingdom Balloon Catheters Market (2017-2032) by End User
7.6.1 Market Overview
7.6.2 Hospitals
7.6.3 Specialty Clinics
7.6.4 Others
8 Germany Ballon Catheters Market (2017-2032)
8.1 Germany Balloon Catheters Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 PTA Balloon Catheters
8.1.3 PTCA Balloon Catheters
8.1.4 Occlusion Balloon Catheters
8.1.5 Foley Catheters
8.1.6 Nephrostomy Balloon Catheters
8.1.7 Drug -Eluting Catheters
8.1.8 Normal Balloon Catheter
8.1.9 Cutting Balloon Catheter
8.1.10 Scoring Balloon Catheter
8.1.11 Drug Eluting Balloon Catheter
8.1.12 Stent Graft Balloon Catheter
8.1.13 Others
8.2 Germany Balloon Catheters Market (2017-2032) by Catheter Type
8.2.1 Market Overview
8.2.2 Fixed Wire
8.2.3 Over -The -Wire
8.2.4 Rapid Exchange
8.3 Germany Balloon Catheters Market (2017-2032) by Balloon Type
8.3.1 Market Overview
8.3.2 Non-Compliant
8.3.3 Semi-Compliant
8.3.4 Compliant
8.4 Germany Balloon Catheters Market (2017-2032) by Material
8.4.1 Market Overview
8.4.2 Polyurethane
8.4.3 Nylon
8.4.4 Others
8.5 Germany Balloon Catheters Market (2017-2032) by Indication
8.5.1 Market Overview
8.5.2 Coronary Artery Disease
8.5.3 Peripheral Vascular Disease
8.6 Germany Balloon Catheters Market (2017-2032) by End User
8.6.1 Market Overview
8.6.2 Hospitals
8.6.3 Specialty Clinics
8.6.4 Others
9 France Ballon Catheters Market (2017-2032)
9.1 France Balloon Catheters Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 PTA Balloon Catheters
9.1.3 PTCA Balloon Catheters
9.1.4 Occlusion Balloon Catheters
9.1.5 Foley Catheters
9.1.6 Nephrostomy Balloon Catheters
9.1.7 Drug -Eluting Catheters
9.1.8 Normal Balloon Catheter
9.1.9 Cutting Balloon Catheter
9.1.10 Scoring Balloon Catheter
9.1.11 Drug Eluting Balloon Catheter
9.1.12 Stent Graft Balloon Catheter
9.1.13 Others
9.2 France Balloon Catheters Market (2017-2032) by Catheter Type
9.2.1 Market Overview
9.2.2 Fixed Wire
9.2.3 Over -The -Wire
9.2.4 Rapid Exchange
9.3 France Balloon Catheters Market (2017-2032) by Balloon Type
9.3.1 Market Overview
9.3.2 Non-Compliant
9.3.3 Semi-Compliant
9.3.4 Compliant
9.4 France Balloon Catheters Market (2017-2032) by Material
9.4.1 Market Overview
9.4.2 Polyurethane
9.4.3 Nylon
9.4.4 Others
9.5 France Balloon Catheters Market (2017-2032) by Indication
9.5.1 Market Overview
9.5.2 Coronary Artery Disease
9.5.3 Peripheral Vascular Disease
9.6 France Balloon Catheters Market (2017-2032) by End User
9.6.1 Market Overview
9.6.2 Hospitals
9.6.3 Specialty Clinics
9.6.4 Others
10 Italy Ballon Catheters Market (2017-2032)
10.1 Italy Balloon Catheters Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 PTA Balloon Catheters
10.1.3 PTCA Balloon Catheters
10.1.4 Occlusion Balloon Catheters
10.1.5 Foley Catheters
10.1.6 Nephrostomy Balloon Catheters
10.1.7 Drug -Eluting Catheters
10.1.8 Normal Balloon Catheter
10.1.9 Cutting Balloon Catheter
10.1.10 Scoring Balloon Catheter
10.1.11 Drug Eluting Balloon Catheter
10.1.12 Stent Graft Balloon Catheter
10.1.13 Others
10.2 Italy Balloon Catheters Market (2017-2032) by Catheter Type
10.2.1 Market Overview
10.2.2 Fixed Wire
10.2.3 Over -The -Wire
10.2.4 Rapid Exchange
10.3 Italy Balloon Catheters Market (2017-2032) by Balloon Type
10.3.1 Market Overview
10.3.2 Non-Compliant
10.3.3 Semi-Compliant
10.3.4 Compliant
10.4 Italy Balloon Catheters Market (2017-2032) by Material
10.4.1 Market Overview
10.4.2 Polyurethane
10.4.3 Nylon
10.4.4 Others
10.5 Italy Balloon Catheters Market (2017-2032) by Indication
10.5.1 Market Overview
10.5.2 Coronary Artery Disease
10.5.3 Peripheral Vascular Disease
10.6 Italy Balloon Catheters Market (2017-2032) by End User
10.6.1 Market Overview
10.6.2 Hospitals
10.6.3 Specialty Clinics
10.6.4 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Abbott Laboratories
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Becton Dickinson and Company
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Boston Scientific Corporation
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Bard Medical Division
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 B.Braun Melsungen AG
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Johnson & Johnson
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Teleflex Incorporated
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Medtronic, Plc.
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Edwards Lifesciences Corporation
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Vascular Solutions,Inc.
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Europe Balloon Catheters Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The Europe balloon catheters market is expected to be driven by the rising demand for the global balloon catheters market, which is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 and is likely to reach a market value of USD 8.1 billion by 2032.
The high prevalence rate of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is fuelling the demand for the market.
One of the significant trends in the market is the increased merger and acquisition activities to accelerate the market expansion of complex coronary interventions including balloon catheter technology. In June 2023, Netherlands-based balloon catheter manufacturer Blue Medical Devices was acquired by Translumina to expand its intervention cardiology portfolio.
Based on the product type, the market is segmented into PTA balloon catheters, PTCA balloon catheters, occlusion balloon catheters, foley catheters, nephrostomy balloon catheters, drug-eluting catheters, normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, and stent graft balloon catheter, among others.
Based on the catheter type, the market is segmented into fixed wire, over-the-wire, and rapid exchange catheter.
Based on the balloon type, the market includes non-compliant, semi-compliant, and compliant catheters.
Based on the material, the market includes polyurethane, and nylon, among others.
Based on indication, the market includes coronary artery disease and peripheral vascular disease.
Major end users include hospitals and specialty clinics, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B.Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc., Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.